JARED BREESE: Open Payments
NPI 1619380102 · SCOTTSDALE, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,084 in 83 payments from 24 companies in 2025. Trend: 2023 $429 · 2024 $126 · 2025 $2,084
Food & beverage: $2,019Education: $65
| Company | Payments | Amount |
|---|---|---|
| Incyte Corporation | 6 | $308 |
| GENZYME CORPORATION | 12 | $281 |
| Janssen Biotech, Inc. | 8 | $230 |
| UCB, Inc. | 9 | $153 |
| ABBVIE INC. | 7 | $148 |
| Regeneron Healthcare Solutions, Inc. | 5 | $139 |
| Novartis Pharmaceuticals Corporation | 4 | $115 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 5 | $109 |
| Organon LLC | 5 | $100 |
| Hill Dermaceuticals, Inc. | 2 | $71 |
Products named: DUPIXENT, OPZELURA, TREMFYA, Bimzelx, SKYRIZI, Rhapsido, VTAMA, Tolak.
Industry payments across AZ — which companies pay providers there.
